A bacterial cell can have more than one plasmid, will express the genes on those plasmids and will replicate each plasmid when it divides. In this way, each daughter cell will get a copy of the plasmid. Plasmids are often used for cloning purposes since genes of interest fragments of DNA can be inserted into plasmids and introduced into the bacteria by bacterial transformation. In bacterial transformation, competent bacteria where the cell wall has been made permeable to genetic material can take up a foreign plasmid.
The bacteria that have taken up the plasmid can be selected for usually by growing the bacteria in a certain antibiotic to which the plasmid DNA allows resistance. In this way, as the bacteria divide the plasmid and thus the genes on them will be amplified. These are enzymes that cut DNA at specific recognition sites that are usually 4 to 8 base pairs in length. The sites are usually also palindromic, meaning they read the same forwards and backward. These ends can be used to insert the gene of interest into a plasmid by ligation.
Blunt end where all bases are paired after a cut. Gel electrophoresis separates molecules of DNA on the basis of their rate of movement through an agarose gel in an electric field. Smaller fragments of DNA will travel faster and thus be farther away from the starting wells. Similarly, proteins can also be separated using electrophoresis. Using restriction enzymes and gel electrophoresis the restriction sites on a segment of DNA, usually a plasmid, can be mapped.
This is useful when trying to identify whether a gene of interest was correctly inserted into the plasmid. Using the circle provided you were to draw and label a restriction map of the resulting gel electrophoresis as well as explain how you came up with the map. So place two EcoRI sites on your circle. Now we look at the fragments that are created by HaeIII.
A 60kb and a 40kb fragment which equals kb as well. So we know there are only two sites where HaeIII cuts as well. Hold off on putting the HaeIII sites. In this case those fragments are 40, 30, 20, and 10kb. I would start by splitting the 70kb into two cuts one of 40kb and one of 30kb. And split the 30kb into one 20kb and one 10kb as shown below. You need to make sure that the HaeIII sites are 60kb from each other one way and 40kb the other. In our map above this is not the case so you should rearrange the numbers.
The resulting map should look something like this. The team named the responsible enzymes "restriction enzymes" because of the way they restrict the growth of bacteriophages. These scientists were also the first to demonstrate that restriction enzymes damage invading bacteriophages by cleaving the phage DNA at very specific nucleotide sequences now known as restriction sites.
The identification and characterization of restriction enzymes gave biologists the means to cut specific pieces of DNA required or desired for subsequent recombination.
Although Griffith and Avery had had demonstrated the ability to transfer foreign genetic material into cells decades earlier, this "transformation" was very inefficient, and it involved "natural" rather than manipulated DNA. Only in the s did scientists begin to use vectors to efficiently transfer genes into bacterial cells. The first such vectors were plasmids, or small DNA molecules that live naturally inside bacterial cells and replicate separately from a bacterium's chromosomal DNA.
Scientists had already established that some bacteria had what were known as antibiotic resistance factors, or R factor-plasmids that replicated independently inside the bacterial cell. But scientists knew little about how the different R factor genes functioned. Cohen thought that if there were an experimental system for transforming host bacterial cells with these R-factor DNA molecules, he and other researchers might be able to better understand R-factor biology and figure out exactly what it was about these plasmids that made bacteria antibiotic-resistant.
He and his colleagues developed that system by demonstrating that calcium chloride-treated E. The following year, Stanley Cohen and his colleagues were also the first to construct a novel plasmid DNA from two separate plasmid species which, when introduced into E. Cohen's team used restriction endonuclease enzymes to cleave the double-stranded DNA molecules of the two parent plasmids. Finally, they introduced the newly recombined plasmid DNA into E. The researchers were able to join two DNA fragments from completely different plasmids because, as they explained, "the nucleotide sequences cleaved are unique and self-complementary so that DNA fragments produced by one of these enzymes can associate by hydrogen-bonding with other fragments produced by the same enzyme" Cohen et al.
The same could be said of any DNA—not just plasmids—from two different species. This universality—the capacity to mix and match DNA from different species, because DNA has the same structure and function in all species and because restriction and ligase enzymes cut and paste the same ways in different genomes—makes recombinant DNA biology possible.
Today, the E. This virus makes an excellent vector because about one-third of its genome is considered nonessential, meaning that it can be removed and replaced by foreign DNA i.
As illustrated in Figure 3, the nonessential genes are removed by restriction enzymes the specific restriction enzyme EcoRI is shown in the figure , the foreign DNA inserted in their place, and then the final recombinant DNA molecule is packaged into the virus's protein coat and prepped for introduction into its host cell.
A fourth major step forward in the field of recombinant DNA technology was the discovery of a vector for efficiently introducing genes into mammalian cells. Specifically, researchers learned that recombinant DNA could be introduced into the SV40 virus, a pathogen that infects both monkeys and humans.
The E. The significance of their achievement was its demonstration that recombinant DNA technologies could be applied to essentially any DNA sequences, no matter how distantly related their species of origin. In their words, these researchers "developed biochemical techniques that are generally applicable for joining covalently any two DNA molecules" Jackson et al. While the scientists didn't actually introduce foreign DNA into a mammalian cell in this experiment, they provided proved the means to do so.
The first actual recombinant animal cells weren't developed until about a decade after the research conducted by Berg's team, and most of the early studies involved mouse cells. The beta globins are a family of polypeptides that serve as the subunits of hemoglobin molecules. Another group of scientists had demonstrated that foreign genes could be successfully integrated into murine somatic cells, but this was the first demonstration of their integration into germ cells.
In other words, Costantini and Lacy were the first to engineer an entire recombinant animal albeit with relatively low efficiency. Interestingly, not long after the publication of his team's study, Paul Berg led a voluntary moratorium in the scientific community against certain types of recombinant DNA research. Clearly, scientists have always been aware that the ability to manipulate the genome and mix and match genes from different organisms, even different species, raises immediate and serious questions about the potential hazards and risks of doing so—implications still being debated today.
Since these early studies, scientists have used recombinant DNA technologies to create many different types of recombinant animals, both for scientific study and for the profitable manufacturing of human proteins. For instance, mice, goats, and cows have all been engineered to create medically valuable proteins in their milk; moreover, hormones that were once isolated only in small amounts from human cadavers can now be mass-produced by genetically engineered cells.
In fact, the entire biotechnology industry is based upon the ability to add new genes to cells, plants, and animals As scientists discover important new proteins and genes, these technologies will continue to form the foundation of future generations of discoveries and medical advances.
Cohen, S. Proceedings of the National Academy of Sciences 69 , — Construction of biologically functional bacterial plasmids in vitro. Proceedings of the National Academy of Sciences 70 , — Costantini, F.
Introduction of a rabbit beta-globin gene into the mouse germ line. Nature , 92—94 link to article. Crea, R. Chemical synthesis of genes for human insulin. Proceedings of the National Academy of Sciences 75 , — Jackson, D. Biochemical method for inserting new genetic information into DNA of simian virus Circular SV40 DNA molecules containing lambda phage genes and the galactose operon of Escherichia coli.
Kiermer, V. The dawn of recombinant DNA. Miller, H. FDA on transgenic animals—A dog's breakfast? Nature Biotechnology 26 , — link to article. Zimmerman, S. Enzymatic joining of DNA strands: A novel reaction of diphosphopyridine nucleotide. The strain of E. The only way these bacteria will be able to grow on media that contain the Amphicillin antibiotic is for them to acquire resistance when they are transformed with a plasmid.
If an antibiotic-sensitive bacteria is transformed with the nonrecombinant plasmid, the bacteria could grow on Amp and produce a blue color. Cells that can grow will divide and divide and form colonies. If the bacteria lack a resistance gene, the antibiotic will either kill the cell or prevent it from dividing. Either way, no colonies will form on the media plates.
0コメント